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Abstract 17 
The presence of active pharmaceutical ingredients (APIs) in the environment is of growing concern and 18 
effluents from wastewater treatment works (WwTWs) are one of the major sources. This research 19 
combines the outputs of a multimillion pound UK programme of work to evaluate the fate of APIs in 20 
the wastewater treatment process. A combination of analysis of measured data and modelling has been 21 
applied to 18 APIs, representing a wide range of medicinal application and physico-chemical 22 
characteristics.  Some isomers (for atorvastatin) and metabolites (for sertraline, carbamazepine and 23 
erythromycin) were also included. High variability was observed between removal rates for individual 24 
APIs between WwTW, which after statistical analysis could not be explained by the nominal WwTW 25 
process (e.g. activated sludge or trickling filter). Nor was there a clear relationship between API removal 26 
and physico-chemical parameters such as pKa, charge or log Kow. A publically available sewage 27 
process model, SimpleTreat 4.0 which has been rigorously validated and is now being used for exposure 28 
assessment with REACH legislation for organic chemicals and within the Biocidal Products Regulation 29 
by the European Medicines Agency for APIs, was used to estimate removal rates with which to compare 30 
with measured data. SimpleTreat provided estimates of removal rates within +/- 30% of observed values 31 
for the majority of the APIs measured, with the use of readily available WwTW specific parameters 32 
such as flow, total suspended solids and BOD data. The data and correlations provided in this study 33 
provide support for any future considerations regarding the management of API discharge to the aquatic 34 
environment.   35 
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1. Introduction 40 
 41 
The use of active pharmaceutical ingredients (APIs) is increasing throughout the world owing to the 42 
widening array of treatments offered, increasing affordability and availability (particularly over the 43 
counter sales) combined with a growing population, of which a greater proportion are increasing in age 44 
(Jelic et al., 2011). The main source of occurrence of APIs in the environment is considered to be from 45 
human use of pharmaceuticals, the majority of which are used, excreted and discharged into the 46 
wastewater system (Gardner et al., 2012; Melvin et al., 2016). Owing to the complexity and cost of 47 
monitoring micropollutants in environmental matrices and in some cases, the lack of legislation to drive 48 
regulation, the availability of fate data can be limited within the public domain. Consequently, there is 49 
increasing scrutiny on the levels of APIs entering and being discharged from WwTW (Comber et al., 50 
2018).  51 
 52 
Furthermore, the extent to which of APIs are removed during wastewater treatment can be limited. API 53 
removal rates are dependent on concentrations entering the works, the API’s chemical structure, 54 
solubility, charge, potentially toxicity and the existence of viable bacteria with the requisite 55 
catabolic/biodegradative capabilities. It should be noted, however, that specific mechanisms of removal 56 
are highly complex and in many cases the contribution of individual factors are poorly understood. 57 
Previous studies have demonstrated that API removal efficiency can vary between WwTW treatment 58 
technologies and even within a given works. Consequently, the quality of WwTW effluent is currently 59 
of interest to the pharmaceutical industry seeking better risk assessments, regulators considering 60 
legislation and the water industry in terms of the risks associated with their effluents entering the aquatic 61 
environment (Gardner et al., 2013). 62 
 63 
The range of concentrations found for pharmaceuticals studied in the UK is similar to that observed in 64 
continental Europe as well as in the USA (Ashton et al., 2004 and Hope et al., 2012). Most often 65 
published data in the literature shows API concentration of less than 100 ng/l in the surface and 66 
groundwater, and below 50 ng/l in treated drinking water (WHO, 2011). This is considerably below the 67 
human therapeutic dose and any acute toxic limit values for the vast majority of APIs. There is, 68 
however, concern regarding potential toxicity and impacts on antimicrobial resistance to the 69 
environment when exposed to mixture of APIs and other chemicals and non-chemical stressors (Bound 70 
et al., 2006). Many countries have initiated various monitoring programs to investigate the exposure of 71 
APIs and to get a better understanding of the pathways and emission sources (Falås, 2012). The 72 
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Chemical Investigation Program (CIP) in the UK is a large ongoing monitoring programme for priority 73 
chemicals, including emerging contaminants such as APIs in WwTW influent, intermediate processes 74 
and effluent as well as their impacts on concentrations in receiving waters (Gardner et al., 2013). The 75 
first phase of the CIP (known as CIP1) was an extensive project that ran from 2012-2015 with the 76 
primary aim to investigate the fate of trace substances in influent, effluent and within the WwTW 77 
process. The result from this extensive investigation has been reported previously (Gardner et al., 2012; 78 
Gardner et al., 2013; Jones et al., 2013, Comber et al., 2014 and Comber et al., 2018). With respect to 79 
process data, removal of 11 commonly detected APIs at 25 WwTWs (on 26 occasions) were reported 80 
for influent, primary, secondary and where present, tertiary treatment effluents (Comber et al., 2018). 81 
The £140 million investment in second phase of the CIP (known as CIP2) builds on the outputs from 82 
CIP1 by extending the range to include the monitoring of a larger number of analytes, and by including 83 
river sampling upstream/downstream of WwTW discharges to measure impact on receiving waters. In 84 
total, over 60,000 samples have been taken, resulting in over 3 million determinations. CIP2 includes 85 
data for 23 APIs (including some metabolites and isomers) for influent and effluent at 44 WwTW, 86 
sampled on 20 occasions (Figure 1; Comber et al., 2018). Furthermore, CIP1 and CIP2 include sanitary 87 
parameters (total suspended solids (TSS), biochemical oxygen demand (BOD), chemical oxygen 88 
demand (COD), pH, dissolved and total organic carbon (DC, TOC), nitrate and phosphate (Gardner et 89 
al., 2013).  90 
 91 
Household wastewater quality will vary depending on such things as behaviour and lifestyle, with many 92 
sewerage systems also containing stormwater which may also contain APIs (Munro et al., 2019). The 93 
sanitary determinands are measured routinely as they are often listed on permits to discharge effluents 94 
to receiving waters. The concentrations of these ‘sanitary’ parameters of BOD, COD, TSS, ammonia 95 
define the character of the effluent and provide an indication of works performance based on 96 
concentrations (lower concentrations suggest higher works efficiency). The presence of APIs is not 97 
measured on a routine basis for most WwTWs owing to cost and lack of legislative drivers. 98 
Furthermore, modern risk assessments and chemical management are increasingly reliant on models to 99 
predict the fate of chemicals through pathways and fate in the environment. Models often provide 100 
predictions of treatment efficiency and effluent concentrations which may then be used in tiered risk 101 
assessments and environmental regulation. There are a number of software tools available which to 102 
various degrees can model the removal of chemicals through the wastewater treatment processes. Over 103 
20 computer programs developed by academia, environmental agencies and commercial sources have 104 
been recognised for predicting fate in WwTW (Crechem et al., 2006). 105 
 106 
4 
 
 107 
 108 
Figure 1: Summary from the CIP 2 program for API median fraction remaining from 44 WwTW 109 
sampled on 20 occasions (Comber, 2018). Note the abbreviations used here are used 110 
throughout this paper.  111 
 112 
 113 
SimpleTreat is a fundamental tool used on an official EU level for predicting exposure in the 114 
environmental risk assessment. Among others, it is the formally recommended model for the essential 115 
assessment for chemical covered in the EU directive of Registration, Evaluation, Authorisation and 116 
restriction of Chemicals (REACH), as well as for the market authorisation of new pharmaceuticals 117 
regulated by European Medicines Agency (EMA) (Franco et al., 2013; EMA et al., 2006). The tool is 118 
straightforward to use and requires the input of a limited number of chemical properties parameters: 119 
molecular weight (MW), vapour pressure, water solubility, n-Octanol/Water Partition Coefficient (Kow) 120 
as well as the results from biodegradability assessments, as defined by the Organisation for Economic 121 
Co-operation and Development (OECD) guidelines (RIVM, 2013). For basic and acidic compounds, 122 
the acid dissociation constant, pKa is also required to take account the state of ionization of polar 123 
molecules in the wastewater (Franco et al., 2013). However, it should be noted that many APIs have 124 
more than 1 pKa value (although rarely do both occur within expected environmental pH conditions) 125 
which cannot be accommodated within the current model and that for ionisable substances such as APIs 126 
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logD incorporating the ionization potential of the chemical within the partitioning calculations would 127 
be potentially an improvement. However, previous studies have suggested that SimpleTreat predicts 128 
total removal to an accuracy of ±5% compared with the measured values for the majority of routine 129 
wastewater determinands which included non-polar persistent organic pollutants but also ionisable 130 
compounds such as triclosan (pKa=8) (Crechem et al., 2006). 131 
 132 
Data from CIP therefore offers the opportunity for a detailed examination of the variability of API 133 
removal efficiency in light of works type and performance. Specifically, this study utilizes CIP2 134 
program outputs, reporting the presence of 23 APIs (including five metabolites of parent APIs) in 135 
influent and effluents, combined with CIP1 data on efficiency of 11 API removal from WwTW 136 
secondary process, split into Activated Sludge Plants (ASP) and Trickling Filter works (TF) processes. 137 
These data, combined with the use of SimpleTreat modelling, has made possible a critical evaluation of 138 
removal efficiency at WwTWs, as well as a comparison of monitoring data with default biodegradation 139 
constants provided in the literature and the accuracy of modelling using the accepted risk assessment 140 
models. By gaining a better understanding of the key factors controlling the removal of APIs during 141 
wastewater treatment combined with an assessment of the effectiveness of modelling will inform future, 142 
focused investments as well as more accurate and prioritized targeted risk assessments (Gardner et al., 143 
2013). 144 
 145 
2. Materials and methods 146 
 147 
2.1 API selection  148 
The selection of chemicals for CIP1 (Gardner et al., 2012) and CIP2 (Comber et al., 2018) are discussed 149 
in detail elsewhere. Briefly, APIs were selected based on a risk assessment approach by comparing the 150 
estimated environmental concentrations of nearly 150 pharmaceuticals (screened on usage and 151 
perceived hazard from a list of approximately thousand candidate substances) with data for their 152 
respective effect concentrations on a variety of receptor organisms in the aquatic environment (UKWIR, 153 
2014). For the purposes of CIP2, the list was further refined by selection of substances that were likely 154 
to occur in effluents after treatment and that were considered to have the greatest potential as candidates 155 
for inclusion on the WFD priority substance list (EU, 2011). This resulted in the list of substances 156 
(n=13) tabulated in Table A1 of the Electronic Supplementary Information (ESI).  157 
 158 
 159 
2.2 Sampling strategy  160 
A set number of WwTW were selected for the CIP1 and 2 programs with the justification for which are 161 
described elsewhere (Comber et al., 2018), being based on a combination of low dilution in the receiving 162 
water, representative types of works (roughly evenly split between ASP and TF), geographic location 163 
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(covering England, Scotland and Wales), and size (serving populations between 2,000 and 1.6 million). 164 
Owing to the varying hydraulic retention times (HRT) for individual works, which are often not 165 
accurately known and can be measured in days (Ejhed et al., 2016) meant it was not practical to try and 166 
match collection of influent and effluent related to the HRT of the selected WwTW. However, given 167 
the mixing that occurs within a given WwTW, combined with sludge returns, inputs from storm tanks 168 
and combined sewers it was decided that sample replication based on numerous sampling occasions 169 
would derive statistically robust conclusions regarding WwTW performance.      170 
 171 
Data used for this research were (Table A2 in the ESI): 172 
 CIP1 program: 25 WwTW data for influent, after primary settlement and final effluent after  173 
secondary and if available tertiary process for 11 APIs. Two samples of each process (spaced 174 
more than 4h apart to provide a degree of replication) were taken on between 10 and 15 175 
occasions between 2011 and 2013. In this part of the programme two samples.  176 
 CIP2 program: Single samples for 18 APIs and 5 metabolites were spot sampled on 20 177 
occasions at 44 WwTWs in the influent and effluent (not intermediate process stages, unlike 178 
CIP1) over a two-year period between 2015 and 2017.  179 
 180 
A summary of the CIP sampling strategies is provided in Table A3. Grab samples at various time 181 
intervals were used for the collection of aqueous samples. To assess variability within the day, in the 182 
CIP1 program, at least one duplicate sample was taking during the same day with a minimum of four-183 
hour period between the sampling. Composite samples were not considered owing to concerns 184 
regarding sample stability. A minimum of 15% of the samples were taken at non-working hours 185 
(evenings and weekends). The sampling schedule was conducted according to stratified random 186 
strategy, indicating that the sampling events are spaced approximately evenly during the year at monthly 187 
intervals, but are randomly placed at each interval in the month. 188 
 189 
2.2 Laboratory analysis 190 
Samples were collected in stainless steel samplers, stored in glass container and transported at 4° C to 191 
the analysis laboratories. The samples were stored a maximum of 5 days prior to analysis. The samples 192 
for measuring the endocrine disrupting chemicals were preserved by adding 30% hydrochloric acid and 193 
copper nitrate (Gardner et al., 2012). The quality assurance/quality control procedures were conducted 194 
for experiment preparation, sample collection, sample pre-treatment and analysis for both laboratory 195 
tests and field sampling. All the samples were analysed by any of four approved laboratories with 196 
ISO17025 accreditation and showed to be able to achieve the analytical performance and quality 197 
assurance laid down in the specification (see A1 of ESI). The pharmaceuticals were analysed by LC-198 
MS or GS-MS. The analytical error of all the pharmaceutical measured were considered to be ±50% 199 
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(25% random error and 25% systematic error) or the Limit of Detection (LOD) if this value was larger 200 
(Table A4). In accordance to EU regulations, if analysed concentrations were below LOD then the value 201 
for LOD was halved to generate a result (EC, 2009). There were no major inter-laboratory error and 202 
inter-regional variation, which would otherwise indicate if there was a bias in the procedure of sample 203 
handling and analysis method. Further details of the proficiency testing can be found in the supporting 204 
information (A1). 205 
 206 
 207 
2.3 Data handling and analysis 208 
The data handling and the statistical analysis were conducted with either Microsoft Excel (2016) or 209 
IBM SPSS Statistics software (version 20). This study also made use of the tool SimpleTreat (version 210 
4.0) for modeling fate in WwTW, application developed by the National Institute for Public Health and 211 
the Environment (RIVM). EPI Suite (version 4.11) was used for retrieving some of the non-published 212 
physico-chemical data, available from the US EPA (US EPA, 2016). 213 
 214 
In the data handling, the replicates were averaged, and this value was then used for further statistical 215 
calculations. Mean, maximum, minimum and percentiles were calculated from the daily average. 216 
Fraction remain was calculated from the influent concentration as a fraction of the various stages of the 217 
process. The removal was calculated as percentage from the concentration based on the effluent 218 
concentration subtracted from the influent then divided by the influent, expressed as a percentage.   219 
 220 
 221 
2.4 SimpleTreat 4.0 (RIVM) emission model  222 
The model SimpleTreat 4.0 (RIVM, 2013) was used for estimating the percentage removal in the 223 
WwTW for a number of the APIs in the CIP program. SimpleTreat is an established, readily available 224 
free to download model often used within regulatory risk assessment frameworks to estimate predicted 225 
environmental concentrations for ASP only (not TF WwTW). Input parameters include noting if the 226 
chemical is potentially ionisable. Given APIs are often charged, the model accommodates by 227 
calculating the proportion of the APIs that is neutral at pH 7.0 and this determines the equation used to 228 
calculate the default organic carbon:water partition coefficient (Koc). Molecular weight, Kow, vapour 229 
pressure and solubility are other required input variables to the model.  Henry’s Law Coefficient (H), 230 
Organic carbon partition coefficient (Koc), Organic carbon partition coefficient for raw and settled 231 
sewage as well as for activated sludge (Kp) can be added as an adjustable input or the model creates a 232 
default value. 233 
 234 
 235 
 236 
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3. Results and discussion 237 
 238 
3.1 Comparison of API data between CIP1 and CIP2  239 
Previous data analysis has shown that the CIP data for APIs in WwTW effluents corresponded well 240 
with those reported elsewhere for UK effluents (Comber et al., 2018). To investigate the quality of the 241 
data, and to examine if there had been any systematic shifts in API effluent concentrations between the 242 
CIP1 the median fraction remaining from both the CIP1 and CIP2 were compared for APIs that were 243 
studied in both programs (E1, E2, EE2, IBPF, DCF, FLXT, PRPL and ERMY). Taking account of the 244 
significant variability of removal efficiencies for individual APIs, good agreement was obtained 245 
between the fraction remaining in effluent of those APIs common to both CIP1 and CIP2 (Figure 2). 246 
These results provided confidence in the analytical data obtained between the two separate programmes 247 
(using different analytical laboratories in some cases) and that there were no gross changes or variations 248 
between the WwTWs selected for sampling or impacts on removal rates associated with the sampling 249 
periods (e.g. seasonality) or methodologies used.   250 
 251 
 252 
Figure 2:  Median fraction remaining after treatment comparing CIP1 (25 WwTW) and CIP2 253 
(44 WwTW) programs. Solid line is the 1:1 line and the dotted line is fitted linear trend 254 
line and error bars are 95% confidence intervals. P value = 4.3x10-5.   255 
 256 
 257 
3.2 Physico-chemical characteristics potentially impacting the API removal in WwTW 258 
APIs can be characterised broadly in terms of their charge and their ability to accept or donate protons; 259 
with carboxylic acid APIs acting as acids and amine groups acting as bases under environmentally 260 
relevant pH conditions. The degree of dissociation (reported as pKa) is crucial when the ambient pH of 261 
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the WwTW effluent is close to the value of the pKa of the API. In some cases, where there are carboxylic 262 
acid and amine groups present on the same compound, depending on the ambient pH, the molecule may 263 
be rendered charge neutral depending on the size of the molecule and spacing between ionisable sites. 264 
The pH of sewage effluent is circumneutral and so for assumption of charge and calculation of LogD, 265 
a pH of 7 was assumed (Gardner et al.,2012) 266 
 267 
This is a particularly important physico-chemical characteristic as the charge on the molecule will in 268 
some degree impact on its affinity for particulate matter, complexation/association with organic matter 269 
and other counter-ions and affect solubility and partitioning and hence bioavailability to microoganisms 270 
(Greenhagen et al., 2014; Tappin et al., 2016). These are all crucial parameters in determining the 271 
removal rate during wastewater treatment. As a general rule, biological uptake is mostly associated with 272 
neutral molecules, particularly if they are also hydrophobic (Haitzer et al., 1999). Positively charged 273 
compounds will show a tendency to sorb strongly to clay minerals and solids which have a 274 
predominantly negative charge. Negatively charged compounds therefore generally have lower affinity 275 
for sorption and uptake, although for complex molecules with multi-protic sites this is somewhat of an 276 
over simplification (Bendz et al., 2005; Katsoyiannis et al., 2007).  277 
 278 
There was no clear relationship between removal rates and groups of acid, basic and neutral APIs 279 
(Figure 3). Poor DCF removal may be a result of the combination of chemical structure, specifically 280 
the presence of halogen functional groups (Verlicchi, 2012) and its hydrophilic nature (log Kow1.5) 281 
reducing bioavailability and increasing persistence. As observed previously (Tappin et al., 2016) the 282 
data show that it is not possible to accurately predict removal of the selected APIs during wastewater 283 
treatment using charge, Log Kow, solubility (LogS), pKa,or LogD which is Kow corrected for the 284 
charge on any given molecule for a specific pH (7.0 assumed in this case). The only conclusion which 285 
may be drawn is that the majority of the basic APIs show poorer removal, possibly owing to reduced 286 
bioavailability of the positively charge molecule (Yamamoto et al., 2009). 287 
  288 
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 290 
 291 
Figure 3:  The order of total fraction remaining (median) for APIs as function of pKa, LogS, 292 
LogD and logKow for the CIP2 and CIP1 APIs not covered by CIP2 (blue colour for 293 
acidic compounds; red for basic; green for neutral or zwitterions) 294 
 295 
 296 
 297 
3.3 Variation in efficiency of API removal by different works technology (ASP vs TF) 298 
Major investments have been made across the UK to upgrade WwTWs from TF to ASP as they are 299 
generally more efficient and reliable in removing BOD and suspended solids, as required by permits to 300 
discharge to receiving waters (Water UK, 2018). The CIP API data were therefore examined to 301 
determine if there were any significant differences in treatment efficiency between TF and ASP (Figure 302 
4, Table A5). The CIP1 data contained 9 TF and 13 ASP WwTWs and the CIP2 data compared 15 TF 303 
and 18 ASP WwTWs APIs percentage removal. For the CIP1 data (Table A5) the secondary process 304 
was separated out (i.e. not total percentage removal) to provide a more accurate comparison with the 305 
CIP2 data.   306 
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 307 
Figure 4: CIP2 mean fractional removal rates for ASP and TF WwTW with 95%ile error bars. 308 
 309 
Data from both CIP1 and CIP2 data, indicate that although in many cases the mean performance for 310 
API removal at ASP works is better than that for TF, which has been reported elsewhere for a different 311 
set of chemicals (Falås, 2012) however, for none of the 23 compounds measured was the difference 312 
statistically significant. What is also noteworthy is the fact that for APIs where removal may be 313 
considered good (e.g. greater than 70%) then variance between works (ASP and TF) are generally lower 314 
than where removal rates are poorer. These data therefore indicate that the type of technology is less 315 
critical for the overall removal efficiency of APIs than WwTW specific processes and characteristics 316 
such as hydraulic retention times, sludge retention times, sludge return management and 317 
biodegradability of the API itself. Another potentially complicating factor is API conjugation. 318 
Metabolic transformations include glucuronidation, sulphation, acetylation of the parent API to increase 319 
solubility and aid excretion. Conjugated metabolites can undergo retransformation back to the parent 320 
form following cleavage of the conjugated moiety which has been hypothesised to occur within WwTW 321 
for estrogens, carbamazepine and diclofenac which are included in the CIP suite of determinands. 322 
Although the potential significance of deconjugation during wastewater treatment has been 323 
acknowledged, detailed empirical evidence is still scarce, being limited to estrogens, because of 324 
analytical challenges (Polesel et al., 2016; Brown and Wong, 2018). As a consequence discussion 325 
relating to absolute removal rates have to be viewed in this light, although comparisons between 326 
different processes is more of a relative comparison.    327 
 328 
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3.4 The relationship between sanitary determinands and pharmaceutical removal  329 
The benefit of gathering concentration data regarding the sanitary determinands (AMON, BOD, COD 330 
and TSS) in combination with that for APIs, allows the ability to seek correlations between metrics 331 
which indicate the overall performance of a WwTW with respect to API removal. If such relationships 332 
can be established, then there are multiple benefits:  333 
 Majority of the WwTW routinely measure the sanitary determinant so this data is already 334 
available. The ability to predict a WwTW’s potential API removal efficiency based on a cheap 335 
and readily available sanitary determinants analysis data, without any issues possibly associated 336 
with time delays with the analysis method and sampling strategy for APIs (Roberts, 2006).  337 
 By extension, the capability of being able to apply the outputs into available models (like for 338 
example SimpleTreat) predicting API removal based on input variables associated with TSS, 339 
AMON, BOD etc. 340 
 Ultimately, allow the potential for optimising WwTW operations (through for example, 341 
hydraulic retention time, increased biological treatment, use of coagulants etc.) to achieve the 342 
desired API removal efficiency without additional expenditure on tertiary treatment.   343 
 344 
Many UK WwTW receive a combination of both crude sewage from domestic and industrial sources 345 
and surface water runoff. Runoff contributes flow but is unlikely to contain APIs or significant BOD. 346 
Industrial discharges are often rich in BOD but their flow in most cases is insignificant compared with 347 
that from domestic sources. Flows and loads of down the drain chemicals such as APIs to WwTW vary 348 
within and between days and seasons; furthermore, the proportion of loads from industrial and domestic 349 
flows may also vary. Consequently, WwTW capacities are generally described as population 350 
equivalents (PE) which is the normalised unit per capita loading, representing the ratio of the sum of 351 
the pollution load produced during 24 hours by industrial facilities and services to the individual 352 
pollution load in household sewage produced by one person in the same time. Given that population 353 
and consented flow data were available for all WwTW (Table A6), an analysis of normalised data was 354 
carried out by multiplying the individual WwTW flow (measured where available, consented otherwise) 355 
and then dividing by the PE, thereby taking account of individual WwTW demographics.  356 
 357 
Any observed correlation between API removal and sanitary determinands is likely to reflect a 358 
combination of works efficiency and API physico-chemical characteristics (Table A7). For example, a 359 
WwTW with high TSS removal suggests efficient settlement and sludge separation and so APIs with a 360 
high tendency to sorb to solids (i.e. high log Koc); alternatively, a high BOD and API removal 361 
correlation suggests the API is susceptible to biodegradation or co-metabolism. Correlations do not 362 
necessarily mean a cause and effect relationship, so there may be other factors influencing the 363 
correlation. Furthermore, this would suggest that the process parameters (PE and flow) probably do not 364 
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account as the only factors for the observed variation in API removal between various plants. PE and 365 
measured/consented flow is an indication of the burden of the plant due to for example the population 366 
size and the industries present in the area; but these are static values and do not take into account the 367 
variability within the year. However, these variations can be seen when looking at the correlation 368 
between the measured sanitary determinands and the APIs removal in the WwTW. It was found that 369 
with or without normalisation of the data the correlation between sanitary determinants and API analysis 370 
concentration was not sufficiently good to allow useably accurate predictions of API concentrations 371 
from sanitary determinand surrogate data (Table A6). There were also no differences seen when 372 
separating out data from TF and ASP technology processes.  373 
 374 
To move beyond simple correlations a Principle Component Analysis (PCA) was performed on the 375 
influent and effluent CIP2 data, where the proximity of determinands on the charts would suggest a 376 
degree of relationship/co-variance. (Figure 5). The data presented, however, largely supports that 377 
generated from the correlation analysis (Table A7). For the influents it can be seen that the sanitary 378 
determinands (BOD, COD, TSS, TP and DOC/TOC) are grouped together showing the expected strong 379 
signal from domestic wastewater which would be likely to contain similar ratios owing to a common 380 
source. The APIs do not relate to the sanitary determinands, most likely owing to their inputs relating 381 
to prescription and/or seasonal use. For the effluents a slightly different pattern is observed. The sanitary 382 
determinands are more separated, likely to be a result of varying treatment (i.e. a potential bias for TSS 383 
removal during primary treatment and BOD by secondary treatment). The APIs reflect this with certain 384 
APIs (e.g. E1, E2, IBPF, ATOVp, METF) more associated with their biodegradability and so align with 385 
BOD. In other words, high performing works reducing BOD to very low levels, are likely to also reduce 386 
the concentrations of more easily degradable APIs. Overall, the lack of clear and distinct groupings 387 
reflects the complexity of removal mechanisms related to this class of compounds as well as the 388 
potential influence of API de-conjugation during the sewage treatment process (Brown and Wong, 389 
2018). Overall, it may be concluded that although there appears loose associations for certain physico-390 
chemical parameters for certain classes of APIs, the biodegradation and partitioning processes with 391 
sewage treatment are highly complex and likely to include other interactions such as electrostatic, 392 
complexation and cation-bridging mechanisms which would be likely to interact with APIs and thus 393 
influence their sorption behaviour and bioavailability (Toll, 2001). However, given APIs often exhibit 394 
low logKow (<4.0) and high solubility, their interaction with the particulate phase during primary 395 
treatment would be expected to be less significant than potential biodegradation loss mechanisms during 396 
secondary treatment (Table A7).    397 
 398 
 399 
 400 
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 401 
Figure 5: Principal component analysis (axes unlabelled as simply pca1 and pca2) of the influents 402 
and effluents for CIP2. CA=calcium; S=sulphur; TP=total phosphorus; SRP=soluble 403 
reactive phosphorus; TOXN=total oxidisable nitrogen. 404 
 405 
 406 
3.6 SimpleTreat 4.0 (RIVM) emission model  407 
The observed variability in estimating API effluent concentrations from sanitary determinands leads 408 
onto the question of whether established models used within the risk assessment process can provide a 409 
better outcome. The freely available model SimpleTreat 4.0 was used for estimating the percentage 410 
removal in the WwTW for a number of the APIs in the CIP program and predictions compared with 411 
observed data from the CIP datasets. The ASP process can be left default or site-specific flow, sewage 412 
solids and BOD can be inputted along with loading rate and pH. Surface aeration (default) or bubble 413 
aeration can be selected as mode of operation. For the purposes of this exercise, given that flows, BOD 414 
and TSS were available for individual WwTW they were input into the model to generate a degree of 415 
WwTW-specific outputs. The key and most sensitive variable however, is the biodegradation rate 416 
employed for the secondary treatment process (hr-1). Data for biodegradation, in particular official 417 
OECD testing data, is not readily available in literature for APIs. A series of defaults are available based 418 
on standard OECD tests which indicate if a compound is readily biodegradable (1 hr-1), readily 419 
biodegradable, failing the 10-day window (0.3 hr-1) and inherently biodegradable fulfilling specific 420 
criteria (0.1 hr-1). Inherently biodegradable, not fulfilling specific criteria or not biodegradable are 421 
assumed to be persistent (0 hr-1). However, for APIs a OECD 301 biodegradability assessment is not 422 
mandated if OECD 308 data are generated, provided the pharmaceutical passes the Phase 1 of the tiered 423 
assessment approach, in other words, it has a PECsurfacewater <10 ng/l and log Kow >4.5 and as well as 424 
certain mode of action (EMEA, 2006). Consequently, not all the APIs in the CIP program could be 425 
estimated in the models (Table A9). When API removal data from both CIP1 and 2 was available, an 426 
average value was used for comparison with SimpleTreat predictions (Figure 6).  427 
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 429 
 430 
Figure 6:  SimpleTreat 4.0 predicted removal versus measured data with 95% confidence        431 
intervals for the CIP1 and CIP2 data (red dotted line=1:1; blue colour for acidic 432 
compounds; red for basic; green for neutral or zwitterions) 433 
 434 
 435 
Overall good agreement was obtained between SimpleTreat and the CIP measured data, with 13 of the 436 
APIs predicted to be within 30% of the CIP measured value, with no obvious systematic bias. This is 437 
in agreement with previously reported assessments (Crechem, 2006). In broad terms, there tended to be 438 
better agreement for neutral/zwitterionic APIs than for the charged compounds (at ambient wastewater 439 
pH). In general, it was found that SimpleTreat tended to under estimate the percentage removal for 10 440 
of the APIs, particularly for those more readily degraded, which being conservative (i.e. there is greater 441 
removal in reality than predicted, so less API is being discharged than predicted) meets the 442 
precautionary principle for risk management (UN, 1992). However, this places potential costs on 443 
society that are not warranted, so it needs to be applied as a screen for further validation.  444 
 445 
Furthermore it was possible to reverse engineer biodegradation rate constants for API removal during 446 
secondary treatment using the SimpleTreat 4.0 model. For CIP1 ASP WwTW data were collected for 447 
influent, as well as after both primary and secondary treatment, unlike the CIP2 WwTW where only 448 
influent and effluent concentrations were measured. Consequently the CIP1 dataset allowed the 449 
efficiency of secondary treatment alone to be calculated as a percentage of API removal. For each of 450 
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the CIP1 WwTW where API concentrations were greater than the limit of detection, API characteristics, 451 
flow, BOD and TSS were input into SimpleTreat and the secondary treatment biodegradation rate 452 
adjusted until the predicted percent removal of the API matched that observed at the WwTW. This 453 
generated a series of rate constants for biodegradation for 9 APIs for between 7 and 13 WwTW 454 
secondary processes. The mean, median and range of these derived rate constants could then be 455 
compared with default constants generated from OECD laboratory tests that are applied in models as 456 
risk assessment to critically assess their efficacy under real-life conditions (Table 1).   457 
 458 
Table 1: Reverse engineered default rate constant generated by SimpleTreat 4.0 using CIP1 459 
secondary ASP removal data.  460 
API 
Default Rate 
constant (hr-1) 
SimpleTreat 4.0 fitted secondary treatment rate 
constant for CIP 1 ASP (hr-1)  
  mean sd median n min max 
DCF 0.3 0.02 0.02 0.003 13 0 0.1 
ERMY 0.3 0.22 0.42 0.038 9 0 1.3 
FLXT 0.3 1.99 2.5 0.325 8 0.002 5 
EE2 0.3 1.77 2.18 0.39 11 0 5 
IBPF 1 0.91 0.54 1.1 9 0.15 1.5 
OXTCY 0.3 0.67 1.34 0.22 13 0 5 
OFLX 0.1 0.84 1.69 0.062 9 0.032 5 
PRPL 0.002 1.19 2.01 0.038 7 0.019 5 
E2 0.3 2.81 2.15 2.2 11 0.3 5 
 461 
By using a combination of the SimpleTreat model and observed CIP1 secondary removal data, it was 462 
possible to fit a biodegradation rate for secondary treatment and compare it with default OECD derived 463 
values (Table 1). Firstly, given the variability in the datasets, fitted first order degradation rates varied 464 
considerably, with maximum and minimum varying by 2 orders of magnitude in some of cases, although 465 
all of the APIs tested, apart from DCF, default degradation rate lay between the observed minimum and 466 
maximum value. As already notes DCF, the steroid estrogens and CBAZ may be susceptible to undergo 467 
de-conjugation during the treatment process and so observed ‘removal rates’ may not reflect modelled 468 
assumptions or ready test biodegradation data; although the latter would be subject to similar possible 469 
microbiological interactions (Brown and Wong, 2018). The median CIP1 fitted degradation rate was 470 
within a factor of 2 of the default for OFLX, OXTCY, FLXT, IBPF and EE2; within an order of 471 
magnitude for ERMY and E2, but the default rate constant was considerably higher for the anionic DCF 472 
and lower for the cationic PRPL. In regulatory risk assessments it is often assumed that there is zero 473 
WwTW removal and in most cases there are no risks and hence there is little need to refine; hence few 474 
WwTW data are currently generated. However, from a conservative risk assessment point of view, a 475 
default degradation rate being lower than observed is desirable, as it will lead to an over estimate/worst 476 
case for effluent concentration and hence PEC. This was the case for four of the APIs, but given that 477 
another three were within a few % of the fitted values, as well as E2 and PRPL, where PECs could be 478 
generated significantly lower than likely observed concentrations, owing to the over optimistic 479 
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degradation rates being applied. However, taking account to that the WwTW conditions of BOD, TSS, 480 
partitioning to sludge etc, overall removal rates for PRPL are close between observed and predicted, 481 
although DCF SimpleTreat removal estimates are significantly higher than observed, owing to the much 482 
higher degradation rate applied.         483 
 484 
Overall, the SimpleTreat estimates of API removal are encouraging and the application of easily 485 
available WwTW metrics (flow, TSS, BOD) allows accurate predictions to be used which would allow 486 
for tentative risk assessments to be undertaken where measured data are not available.  487 
 488 
Finally, it is important to consider the wider impacts of these finding, particularly relating to the risk 489 
assessments required for chemicals likely to enter the environment. Provide sufficient data is available 490 
then a similar approach should be able to be applied to other substances of concern that occur in 491 
wastewater including illicit drugs, pesticides and other classes of APIs such as antiretrovirals (Munro 492 
et al., 2019). Furthermore, reverse engineering biodegradation half-lives using monitoring data is quite 493 
an expensive way to achieve this and can only be done reliably once an API is in patient use and after 494 
WwTWs have adapted to potentially biodegrade the compound.  APIs are ‘down the drain’ chemicals 495 
and current regulations from the EMA require the determination of LogKoc and LogKow as well as the 496 
OECD 301 (ready biodegradability) and 308 (aerobic and anaerobic transformation) tests. Using 497 
SimpleTreat to reverse fit secondary treatment biodegradation rates showed that a wide variation in rate 498 
constants are generated, reflecting the observed data, with median values which can differ considerably 499 
from values generated from OECD ready biodegradation tests. The likely reason for these differences 500 
are the artificial conditions used within such tests, in particular, fixed temperatures, elevated API 501 
concentrations, low biomass concentrations and variable inoculums (Martin et al.,2018). There is no 502 
requirement to conduct a 314B (activated sludge die-away) or 303 (aerobic sewage simulation) tests 503 
within the required ERA for EMA. Given the variation in removal observed at WwTW and the need to 504 
get a realistic PEC for surface waters, so that those APIs of greatest risk can be prioritised, the EMA 505 
guidelines may need to be amended to reflect this. This might include giving greater consideration to 506 
WwTW removal in Phase II Tier A and/or B. The draft revision out for consultation (EMA, 2018) 507 
allows the OECD 301 test to be waived if the OECD314B test has been completed, which is a positive 508 
move and the results presented here do support the need for greater consideration of WwTW within the 509 
ERA process.  The application of this approach might also help the water industry to prioritise on those 510 
drugs with low removal much earlier. 511 
 512 
4 Conclusions 513 
 514 
The removal of APIs observed between and within the individual WwTW is shown by CIP monitoring 515 
to be highly variable and of greater significance than any variance between overall type of treatment 516 
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(e.g. ASP versus TF). There was no usable correlation found between concentrations of sanitary 517 
determinands such as AMON, BOD, COD and TSS and observed those of APIs. The only conclusion 518 
that could be drawn was that high performing WwTWs (with high levels of sanitary determinand 519 
removal) lead to the strong likelihood that APIs too, will be more effectively removed. Relatively 520 
accurate estimates of removal were achievable using the latest version of the SimpleTreat model for 521 
ASP WwTWs, which accounts for the charge present, a significant (but not only) controlling factor in 522 
the fate of APIs during wastewater treatment. SimpleTreat was capable of predicting API removal with 523 
an uncertainty of +/- 30% for the majority of the APIs tested, based on readily available WwTW specific 524 
parameters such as flow, total suspended solids and BOD. This has been achieved without any account 525 
of processes such as de-conjugation which is poorly understood at the present time.  526 
 527 
Overall, it may be concluded that SimpleTreat using some easily obtainable WwTW parameters such 528 
as TSS and BOD concentrations, offers a relatively refined modelling option for API risk assessment 529 
purposes, provided there is confidence in the degradation rate constants used. The data and modelling 530 
presented  here supports the move towards greater consideration of WwTW within the ERA process for 531 
APIs.     532 
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